Objectives:
- Discuss tumor-intrinsic mechanisms of immune response and resistance
- Discuss current work examining the role of tumor-cell-intrinsic HIF1a activation in mediating immune evasion and resistance to immunotherapy
- Discuss current work investigating whether WNT/β-catenin activation mediates immune resistance in mismatch-repair deficient tumors
Session date:
12/10/2018 - 12:00pm to 1:00pm CST
Location:
UCMC
5841 South Maryland Avenue
MC2115, HemOnc Conference Room E215
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Jonathan A. Trujillo, MD, PhD